Browse our catalogue of products
146 products displayed
| Ref-SKU | Type | Product | Description | ICTV Taxonomy | Virus name | Strain | Isolate | Product Grading | Availability | Product Risk Group | Provider | Cost per Access (Academics) | More info | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 001V-05956 | Virus | Enterovirus A71, strain UVE/EV-A71/2016/GR/268854 | Frozen Enterovirus A71, strain UVE/EV-A71/2016/GR/268854, Greece 2016, complete ORF sequence. | Enterovirus A | Enterovirus A71 | UVE/EV-A71/2016/GR/268854 | Gold | In stock | RG2 | AMU | 500€ | View all details on this product . . . | Free access available | |
| 001V-05955 | Virus | Echovirus 30, strain UVE/E-30/2012/GR/10 | Frozen Echovirus 30, strain UVE/E-30/2012/GR/10, Greece 2012, complete ORF sequence | Enterovirus B | Echovirus 30 | UVE/E-30/2012/GR/10 | Gold | In stock | RG2 | AMU | 500€ | View all details on this product . . . | Free access available | |
| 001V-05953 | Virus | Coxsackievirus A24, strain UVE/CV-A24/2017/GR/25 | Frozen Coxsackievirus A24, strain UVE/CV-A24/2017/GR/25, Greece, 2017, complete ORF sequence | Enterovirus C | coxsackievirus A24 | UVE/CV-A24/2017/GR/25 | Gold | In stock | RG2 | AMU | 500€ | View all details on this product . . . | Free access available | |
| 001V-05954 | Virus | Coxsackievirus B5, strain UVE/CV-B5/2017/GR/13 | Frozen Coxsackievirus B5, strain UVE/CV-B5/2017/GR/13, Greece 2017, complete ORF sequence | Enterovirus B | Coxsackievirus B5 | UVE/CV-B5/2017/GR/13 | Gold | In stock | RG2 | AMU | 500€ | View all details on this product . . . | Free access available | |
| 001V-05952 | Virus | Echovirus 6, strain UVE/E-6/2016/GR/10 | Frozen Echovirus 6, strain UVE/E-6/2016/GR/10, complete sequence, Greece 2016 | Enterovirus B | echovirus 6 | UVE/E-6/2016/GR/10 | Gold | In stock | RG2 | AMU | 500€ | View all details on this product . . . | Free access available | |
| 006N-03078 | Nucleic Acid |
HIV-1 pNL-_rtD67N
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the reverse transcriptase gene, which can confer drug resistance to specific HIV-1 inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on reverse transcriptase inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-02570 | Nucleic Acid | HIV-1 pNL-BX_pr48V | HIV-1, drug resistant point mutant of protease, reported to be selected in vivo during treatment with protease inhibitors, including saaquinavir. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-03077 | Nucleic Acid |
HIV-1 pNL-BX_prM36V
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03074 | Nucleic Acid |
HIV-1 pNL-BX_prL90M
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03081 | Nucleic Acid |
HIV-1 pNL-BX_prL10I
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03084 | Nucleic Acid |
HIV-1 pNL-BX_pr-L33F
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03076 | Nucleic Acid |
HIV-1 pNL-BX_pr-L24I
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03083 | Nucleic Acid |
HIV-1 pNL-BX_pr-K20R
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03075 | Nucleic Acid |
HIV-1 pNL-BX_pr-L10F
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03082 | Nucleic Acid |
HIV-1 pNL-BX_pr-M46I
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-02608 | Nucleic Acid |
HIV-1 pNL-BX_prL63P-A71V-V82T-I84V
Antiviral resistant strain |
Protease mutant with discrete mutations relevant for drug resistance to protease inhibitors | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-02602 | Nucleic Acid |
HIV-1 pNL-BX_prM46I-I47L-I50V-V82A-I84V
Antiviral resistant strain |
Protease mutant with the indicated discrete mutations relevant for drug resistance to protease inhibitors | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-02575 | Nucleic Acid |
HIV-1 pNL-BX_pr84V
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, selected by specific HIV protease inhibitors. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-02574 | Nucleic Acid |
HIV-1 pNL-BX_pr84A
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, selected by specific HIV protease inhibitors in vivo | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-02572 | Nucleic Acid |
HIV-1 pNL-BX_prI50L
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, reported to be specifically selected by the HIV protease inhibitor atazanavir in vivo | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-02573 | Nucleic Acid | HIV-1 pNL-BX_prI54V | HIV-1, drug resistant point mutant of protease, selected by specific HIV protease inhibitors in vivo | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-02569 | Nucleic Acid | HIV-1 pNL-BX_prA71V | HIV-1, drug resistant point mutant of protease, reported to be selected during treatment with specific HIV protease inhibitors | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-01988 | Nucleic Acid | HIV-1 pNL-BX_prK45I-L76F | Plasmid contains the entire genome of HIV-1 (NL4-3) with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 protease inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on protease inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03072 | Nucleic Acid |
HIV-1 pNL-BX_prV82A
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the viral protease gene, which can confer drug resistance to specific HIV-1 protease inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on protease inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-01922 | Nucleic Acid |
HIV-1 pNL-BX_prL10F-M46I-A71V-V82A-I84V
Antiviral resistant strain |
Recombinant HIV-1 plasmid (derived from pNL4-3) with the indicated mutations in the protease gene, which have been reported in the context of clinical drug resistance to HIV protease inhibitors. | Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 | clade B | The recombinant clone NL4-3 was derived from proviral DNA isolated from human HIV-1 positive cells | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |